Industry
Biotechnology
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 22, 2024 | 1:05 pm
Portfolio Pulse from Benzinga Newsdesk
August 15, 2024 | 1:09 pm
Portfolio Pulse from Benzinga Newsdesk
August 09, 2024 | 3:06 pm
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 4:49 pm
Portfolio Pulse from Benzinga Newsdesk
June 12, 2024 | 7:47 pm
Portfolio Pulse from Benzinga Insights
June 12, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
June 11, 2024 | 7:55 pm
Portfolio Pulse from Benzinga Insights
June 07, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
June 06, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
June 06, 2024 | 7:54 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.